Nkarta Inc Ordinary Shares NKTX
News
Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence
Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
Nkarta to Participate in September Investor Conferences
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
